These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 15198743

  • 1. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G, Ahlin A, Dahllöf G, Elinder G, Henter JI, Palmblad J.
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [Abstract] [Full Text] [Related]

  • 2. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].
    Zeidler C, Reiter A, Yakisan E, Koci B, Riehm H, Welte K.
    Klin Padiatr; 1993 Jul; 205(4):264-71. PubMed ID: 7690865
    [Abstract] [Full Text] [Related]

  • 3. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H, Silbermann S, Weller S, Kirschke R, Körholz D, Janssen G, Göbel U, Nürnberger W.
    Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
    [Abstract] [Full Text] [Related]

  • 4. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P, Andoljsek D, Mlakar U, Pretnar J, Modic M, Zupan IP, Zver S.
    Pflugers Arch; 2000 Aug; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of recombinant human G-CSF in children with cancer].
    Tsukimoto I, Hanawa Y, Takaku F, Asano S, Ueda K, Tsuchida M, Sato T, Ohira M, Hoshi Y, Nishihira K.
    Rinsho Ketsueki; 1990 Oct; 31(10):1647-55. PubMed ID: 1701501
    [Abstract] [Full Text] [Related]

  • 6. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K.
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
    Peddi VR, Hariharan S, Schroeder TJ, First MR.
    Clin Transplant; 1996 Feb; 10(1 Pt 1):20-3. PubMed ID: 8652892
    [Abstract] [Full Text] [Related]

  • 10. The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.
    Morstyn G, Foote M, Perkins D, Vincent M.
    Stem Cells; 1994 Feb; 12 Suppl 1():213-27; discussion 227-8. PubMed ID: 7535147
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
    Heussner P, Haase D, Kanz L, Fonatsch C, Welte K, Freund M.
    Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
    [Abstract] [Full Text] [Related]

  • 14. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias].
    Ueda K, Hanawa Y, Takaku F, Asano S, Tsukimoto I, Tsuchida M, Sato T, Ohira M, Hoshi Y, Nishihira K.
    Rinsho Ketsueki; 1991 Mar; 32(3):212-20. PubMed ID: 1710294
    [Abstract] [Full Text] [Related]

  • 15. Congenital neutropenias.
    Zeidler C, Schwinzer B, Welte K.
    Rev Clin Exp Hematol; 2003 Mar; 7(1):72-83. PubMed ID: 14692235
    [Abstract] [Full Text] [Related]

  • 16. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H, Ninomiya H, Abe T, Saito K, Shishido H, Moriyama Y, Shibata A, Motoyoshi K, Nagata N, Miura Y.
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [Abstract] [Full Text] [Related]

  • 17. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
    Ono M.
    Eur J Cancer; 1994 Feb; 30A Suppl 3():S7-11. PubMed ID: 7535073
    [Abstract] [Full Text] [Related]

  • 18. Comparison of filgrastim and lenograstim in pediatric solid tumors.
    Sarı N, Dalva K, Ilhan IE.
    Pediatr Hematol Oncol; 2013 Oct; 30(7):655-61. PubMed ID: 24050764
    [Abstract] [Full Text] [Related]

  • 19. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V, Ongun H, Yeşilipek MA, Yeğin O.
    Turk J Pediatr; 1999 Oct; 41(1):117-20. PubMed ID: 10770686
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N.
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.